Laurence Guy Howes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laurence Guy Howes has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ameer Hamza
Amtan Medical General Practice, Australia
2 shared publications - Jan Beatrice Howes
Amtan Medical General Practice, Australia
2 shared publications - Rohan Jayasinghe
Gold Coast Hospital, Australia
2 shared publications - Tanya Unni
Amtan Medical General Practice, Australia
2 shared publications - Gurjeevan Kaur
Gold Coast Health, QLD 4215, Australia
1 shared publication - Hendrika Laetitia Hattingh
Allied Health Research, Gold Coast Hospital and Health Service, Southport, Australia
1 shared publication
Latest Publications
- Open Access
- 6 January 2025
- Published by MDPI AG in Preprints.org
The Effect of Combination Antioxidant Therapy on Reflexion Index (RI), a Measure of Resistance Vessel and Small to Medium Artery Compliance
Antioxidants reduce arterial stiffness but the effects previously reported are weak. The effect of 2 weeks of therapy with a combination of antioxidants (l-cysteine, thiamine, pyridoxine and ascorbic acid) on reflexion index, a measure of resistance vessel and small to medium artery compliance, were studied using a Pulse Trace digital photoplethysmography recorder in 40 subjects compared to 38 subjects on placebo. Reflection index fell by -8% (placebo corrected) (95% confidence intervals -1% to -15%, P = 0.0422) on antioxidant therapy. The reduction in resistance index was positively correlated with increasing age in subjects on antioxidant therapy (r = 0.354, P= 0.0220) but not in subjects on placebo (r = 0.125, P = 0.4520). Resistance index was reduced to a smaller extent than the previously reported -19% (95% confidence intervals -9% to -30%, P=0.0020) reduction in stiffness index (a measure of pulse wave velocity, or central artery stiffness) recorded at the same time (effect size: reflection index = 1.0, stiffness index = 1.5). Combination antioxidant therapy significantly reduced reflection index, but the effect on stiffness index was greater.
- 6 January 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Effect of Combination Antioxidant Therapy on Reflexion Index (RI), a Measure of Resistance Vessel and Small to Medium Artery Compliance
Antioxidants reduce arterial stiffness but the effects previously reported are weak. The effect of 2 weeks of therapy with a combination of antioxidants (l-cysteine, thiamine, pyridoxine and ascorbic acid) on reflexion index, a measure of resistance vessel and small to medium artery compliance, were studied using a Pulse Trace digital photoplethysmography recorder in 40 subjects compared to 38 subjects on placebo. Reflection index fell by -8% (placebo corrected) (95% confidence intervals -1% to -15%, P = 0.0422) on antioxidant therapy. The reduction in resistance index was positively correlated with increasing age in subjects on antioxidant therapy (r = 0.354, P= 0.0220) but not in subjects on placebo (r = 0.125, P = 0.4520). Resistance index was reduced to a smaller extent than the previously reported -19% (95% confidence intervals -9% to -30%, P=0.0020) reduction in stiffness index (a measure of pulse wave velocity, or central artery stiffness) recorded at the same time (effect size: reflection index = 1.0, stiffness index = 1.5). Combination antioxidant therapy significantly reduced reflection index, but the effect on stiffness index was greater.
- Open Access
- 17 August 2023
- Published by MDPI AG in Preprints.org
Reduction in Arterial Stiffness Index (SI) in Response to Combination Antioxidant Therapy
Antioxidants reduce arterial stiffness but the effects previously reported are weak. The present study evaluated the effects of 2 weeks of therapy with a combination of antioxidants (l-cysteine, thiamine, pyridoxine and ascorbic acid) compared to placebo on stiffness index (SI) a measure of arterial stiffness that is strongly correlated with central pulse wave velocity (PWV), using a Pulse Trace recorder in a diverse group of 78 volunteers. SI fell by 1.7 m/sec relative to placebo (95% confidence intervals 0.6 to 2.7 m/sec), a reduction of 19% (95% confidence intervals 9% to 31%). The Glass effect size was 1.4, indicating a very strong treatment effect which was substantially greater than found in previous studies of the effects of antioxidant therapy on arterial stiffness. The magnitude of reduction in SI was positively correlated with increasing age (r = 0.362 P = 0.02). The change in RI, a measure of compliance of small to medium size arteries, did not differ between the antioxidant and placebo groups The combination of antioxidants studied reduced PWV to a much greater extent than reported for other antioxidants. This combination may be of value in the treatment of cardiovascular disease.
- 17 August 2023
- Published by MDPI AG in Preprints.org
Open AccessReduction in Arterial Stiffness Index (SI) in Response to Combination Antioxidant Therapy
Antioxidants reduce arterial stiffness but the effects previously reported are weak. The present study evaluated the effects of 2 weeks of therapy with a combination of antioxidants (l-cysteine, thiamine, pyridoxine and ascorbic acid) compared to placebo on stiffness index (SI) a measure of arterial stiffness that is strongly correlated with central pulse wave velocity (PWV), using a Pulse Trace recorder in a diverse group of 78 volunteers. SI fell by 1.7 m/sec relative to placebo (95% confidence intervals 0.6 to 2.7 m/sec), a reduction of 19% (95% confidence intervals 9% to 31%). The Glass effect size was 1.4, indicating a very strong treatment effect which was substantially greater than found in previous studies of the effects of antioxidant therapy on arterial stiffness. The magnitude of reduction in SI was positively correlated with increasing age (r = 0.362 P = 0.02). The change in RI, a measure of compliance of small to medium size arteries, did not differ between the antioxidant and placebo groups The combination of antioxidants studied reduced PWV to a much greater extent than reported for other antioxidants. This combination may be of value in the treatment of cardiovascular disease.
- 19 July 2016
- Published by Springer Nature in Drug Safety
- Vol. 39 (9) , 841-845
Drug Interactions of Direct-Acting Oral Anticoagulants
In recent years, new direct-acting oral anticoagulants (DOACs) have been introduced into clinical practice that specifically inhibit either factor Ia or Xa. These drugs have, to a large extent, replaced warfarin for the treatment of venous thrombosis, pulmonary embolism, and non-valvular atrial fibrillation. They have potential advantages over warfarin in providing more stable anticoagulation and the lack of a need for regular venesection to monitor activity. They also have the promise of less drug and food interactions. All of these drugs are substrates for the permeability glycoprotein (P-gp) excretion system, and several are metabolised, in part, by cytochrome P450 (CYP) 3A4. This current article assesses the interactions that do or may occur with the DOACs, particularly with respect to the P-gp and CYP3A4 systems.
- 19 July 2016
- Published by Springer Nature in Drug Safety
- Vol. 39 (9) , 841-845
Drug Interactions of Direct-Acting Oral Anticoagulants
In recent years, new direct-acting oral anticoagulants (DOACs) have been introduced into clinical practice that specifically inhibit either factor Ia or Xa. These drugs have, to a large extent, replaced warfarin for the treatment of venous thrombosis, pulmonary embolism, and non-valvular atrial fibrillation. They have potential advantages over warfarin in providing more stable anticoagulation and the lack of a need for regular venesection to monitor activity. They also have the promise of less drug and food interactions. All of these drugs are substrates for the permeability glycoprotein (P-gp) excretion system, and several are metabolised, in part, by cytochrome P450 (CYP) 3A4. This current article assesses the interactions that do or may occur with the DOACs, particularly with respect to the P-gp and CYP3A4 systems.
- 20 January 2015
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 29 (1) , 11-16
Assessing the Arrhythmogenic Potential of New Drugs: A Guide for the Pharmaceutical Physician
- 20 January 2015
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 29 (1) , 11-16
Assessing the Arrhythmogenic Potential of New Drugs: A Guide for the Pharmaceutical Physician